1 Product identity
Ingredient risk
No flagged ingredients

Adaptrin

BrandAmerican Medical HoldingsBotanical Tablet or Pill 25 ingredients DSLD #25407
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-09-25
2 Ingredients (25)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)
Lichen islandicusIceland Moss
Costus amanumCostus
Melia loosendanSichuan Pagoda Tree
Elettaria CardamomumCardamom
Pterocarpus santalinusRed Sandalwood
Terminalia chebulaeTropical Almond
Amomum medicinalisAmomum (unspecified)
Aegle sepiarBael
Calcium sulfate monohydrateCalciumConditionally Safe
Aquilegia viridifoliaAquilegia viridiflora
Plantago lanceolataBuckthorn Plantain
Glycyrrhiza glabraLicorice
Polygonum aviculareKnotweed
Potentilla AureaPotentilla aurea
Eugenia caryophyllataClove
Hedychium spicatumSpiked Ginger Lily
Sida cordifoliaSida cordifolia
Valeriana officinalisValerianConditionally Safe
Lactuca sativalettuce
Calendula officinalisCalendula
Camphora japonicumJapanese camphor
Microcrystalline CelluloseCellulose
Silicon DioxideSiliconGenerally Safe
transparent coatingCoating
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
Valerian — Conditionally Safe
⚠ Drowsiness
⚠ Additive with sedatives/alcohol
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID25407
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-09-25
6 More from American Medical Holdings
View American Medical Holdings Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Adaptrin — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 25]. Available from: https://supplement.ge/products/adaptrin-25407/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG